Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 2 |
2016 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
J Clin Invest. 2016 Mar 1;126(3):1052-66. doi: 10.1172/JCI85271. Epub 2016 Feb 15.
J Clin Invest. 2016.
PMID: 26878173
Free PMC article.
NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition.
Garcia-Rendueles ME, Ricarte-Filho JC, Untch BR, Landa I, Knauf JA, Voza F, Smith VE, Ganly I, Taylor BS, Persaud Y, Oler G, Fang Y, Jhanwar SC, Viale A, Heguy A, Huberman KH, Giancotti F, Ghossein R, Fagin JA.
Garcia-Rendueles ME, et al.
Cancer Discov. 2015 Nov;5(11):1178-93. doi: 10.1158/2159-8290.CD-15-0330. Epub 2015 Sep 10.
Cancer Discov. 2015.
PMID: 26359368
Free PMC article.
Item in Clipboard
Therapy: Lenvatinib and radioiodine-refractory thyroid cancers.
Dunn L, Fagin JA.
Dunn L, et al.
Nat Rev Endocrinol. 2015 Jun;11(6):325-7. doi: 10.1038/nrendo.2015.53. Epub 2015 Mar 31.
Nat Rev Endocrinol. 2015.
PMID: 25824678
Free PMC article.
Item in Clipboard
Cite
Cite